Patents by Inventor Vince Laterza

Vince Laterza has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7629171
    Abstract: The present invention relates to genetically altered hybridomas, myelomas and B cells. The invention also relates to utilizing genetically altered hybridomas, myelomas and B cells in methods of making monoclonal antibodies. The present invention also provides populations of hybridomas and B cells that can be utilized to make a monoclonal antibody of interest.
    Type: Grant
    Filed: November 16, 2006
    Date of Patent: December 8, 2009
    Assignee: University of Georgia Research Foundation, Inc.
    Inventors: Richard B. Meagher, Vince Laterza
  • Publication number: 20070207539
    Abstract: The present invention relates to genetically altered hybridomas, myelomas and B cells. The invention also relates to utilizing genetically altered hybridomas, myelomas and B cells in methods of making monoclonal antibodies. The present invention also provides populations of hybridomas and B cells that can be utilized to make a monoclonal antibody of interest.
    Type: Application
    Filed: November 16, 2006
    Publication date: September 6, 2007
    Inventors: Richard Meagher, Vince Laterza
  • Patent number: 7148040
    Abstract: The present invention relates to genetically altered hybridomas, myelomas and B cells. The invention also relates to utilizing genetically altered hybridomas, myelomas and B cells in methods of making monoclonal antibodies. The present invention also provides populations of hybridomas and B cells that can be utilized to make a monoclonal antibody of interest.
    Type: Grant
    Filed: February 20, 2002
    Date of Patent: December 12, 2006
    Assignees: University of Georgia Research Foundation, Inc., Abeome Corporation
    Inventors: Richard B. Meagher, Vince Laterza
  • Publication number: 20030162947
    Abstract: The present invention relates to genetically altered hybridomas, myelomas and B cells. The invention also relates to utilizing genetically altered hybridomas, myelomas and B cells in methods of making monoclonal antibodies. The present invention also provides populations of hybridomas and B cells that can be utilized to make a monoclonal antibody of interest.
    Type: Application
    Filed: February 20, 2002
    Publication date: August 28, 2003
    Inventors: Richard B. Meagher, Vince Laterza